ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 118 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $40,000 | -58.8% | 19,425 | -11.0% | 0.01% | -58.3% |
| Q1 2015 | $97,000 | +21.2% | 21,825 | -7.0% | 0.01% | +9.1% |
| Q4 2014 | $80,000 | -22.3% | 23,475 | -2.5% | 0.01% | -21.4% |
| Q3 2014 | $103,000 | -29.5% | 24,075 | -0.8% | 0.01% | -33.3% |
| Q2 2014 | $146,000 | -11.5% | 24,275 | -15.8% | 0.02% | -32.3% |
| Q1 2014 | $165,000 | -6.2% | 28,833 | -2.1% | 0.03% | 0.0% |
| Q4 2013 | $176,000 | +17.3% | 29,453 | +4.7% | 0.03% | -13.9% |
| Q3 2013 | $150,000 | -27.2% | 28,128 | +7.1% | 0.04% | -18.2% |
| Q2 2013 | $206,000 | – | 26,275 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 7,500,000 | $34,800,000 | 2.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,983,710 | $32,404,000 | 1.08% |
| DAFNA Capital Management LLC | 189,000 | $877,000 | 0.74% |
| Lyons Wealth Management, LLC. | 56,665 | $264,000 | 0.30% |
| Telemetry Investments, L.L.C. | 110,000 | $510,000 | 0.23% |
| Callan Capital, LLC | 232,000 | $1,076,000 | 0.23% |
| OXFORD ASSET MANAGEMENT LLP | 968,446 | $4,494,000 | 0.12% |
| FEDERATED HERMES, INC. | 5,641,200 | $26,175,000 | 0.08% |
| HRT FINANCIAL LP | 31,973 | $148,000 | 0.07% |
| WELLINGTON MANAGEMENT GROUP LLP | 33,885,551 | $157,230,000 | 0.04% |